| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |